Skip to main content

Akzo Nobel N.V.

corporate_fare Company Profile

Akzo Nobel N.V.

AKZOY·OTC·Industrial Applications And Services·CIK 0000003124

Akzo Nobel NV is a diversified, multicultural and truly global company with activities in human and animal healthcare, coatings and chemicals. Operations are organized in segments on the basis of affinity between activities: Human Pharmaceuticals (Organon) and Animal Health (Intervet) together also referred to as Pharma Coatings and Chemicals. Within the Coatings and Chemicals segment, the activities are carried out in business units. The Board of Management is the highest executive authority and is entrusted with the management of the company, defining the strategic direction, establishing the policies, and managing the company's day-to-day operations. The members of the Board of Management collectively manage the company and are responsible for its performance, and are jointly and individually accountable for all decisions made by the Board of Management. At the corporate level, key tasks are coordinated in the fields of strategy; finance; control; human resources; technology; legal affairs and intellectual property; communications; health, safety, and environment; information management; and risk and insurance management. Akzo Nobel aims to create above-average economic value over the business cycle. Capital allocation is focused on building sustainable leading business positions, reflected in attractive growth, returns significantly above the costs of capital, and substantial operational cash flows. The company actively restructures to meet its goals and divests activities where it cannot meet the criteria. It develops competitive advantages by combining the customer focus and entrepreneurial spirit of a decentralized business unit organization with the scale and power of a global organization which provides access to global capital markets, managerial talent, best management practices, and purchasing power.

Akzo Nobel N.V. (OTC:AKZOY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for AKZOY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-13, rated 7/10. Recent SEC coverage for AKZOY spans 6-K.

Recent high-impact activity:

  • Russian Presidential Decree Places AkzoNobel Subsidiaries Under Temporary External Administration

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 65,561 shares in AKZOY as of the October 30, 2026 settlement, a 15.2% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 33.4% of AKZOY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)65,561 shares as of October 30, 2026
Change vs prior period▼ 15.2%
Days to cover1.00 at avg daily volume of 189,508
Daily short volume (FINRA facilities)33.4% of 93,015 shares on November 20, 2026
5-day average short volume44.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

AKZOY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$22.6 -2.21% today
52-week range · as of 2026-07-13 $18.04 – $25.99
Market cap
$11.3B
Volume
93K (0.9× avg)
3-mo avg 101.2K
Live data · 2026-11-22 12:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AKZOY - Latest Insights

AKZOY
Jul 13, 2026, 3:25 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $21.76
Real-time Price: $22.60 info
Change: +$0.840 (+4%) info
Market Cap: $11.297B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets